Days before it was to go into effect, the Trump administration pushed back a U.S. customs rule threatening the supply of vital prescription drugs imported by millions of Americans. Under the rule, ...
Last week MAA ace writer, Emma Hall, introduced us to her piece on the ever increasing show biz influence on […] ...
Lilly heads into Q3 earnings with Mounjaro, Zepbound and new drugs fueling growth, but pricing pressure, rising costs and competition pose challenges.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results